UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4

被引:37
|
作者
Wang, Jin [1 ]
Zhao, Xiaomu [1 ]
Jin, Lan [1 ]
Wu, Guocong [1 ]
Yang, Yingchi [1 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, 95 Yongan Rd, Beijing 100050, Peoples R China
关键词
UBR5; Colorectal cancer; Proliferation; Apoptosis; ECRG4; EPITHELIAL OVARIAN-CANCER; UBIQUITIN LIGASE; CISPLATIN RESISTANCE; CELL-GROWTH; IN-VITRO; GENE; EDD; APOPTOSIS; FUSION; LINE;
D O I
10.1007/s10620-017-4732-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The E3 ligase UBR5 is aberrantly expressed in diverse types of cancer. However, its expression pattern and biological function in colorectal cancer (CRC) remain unclear. We used RT-PCR, Western blot, and immunohistochemistry to measure UBR5 expression in CRC tissues and corresponding non-tumor tissues. The expression pattern of UBR5 in CRC tissues was determined by scoring system of immunohistochemical analysis and mRNA level by RT-PCR. The statistical analyses were applied to evaluate the associations of UBR5 expression with survival rate of patients. The UBR5 gene was overexpressed or silenced with lentiviral vectors in CRC cells. And, cell proliferation and apoptosis were measured using CCK8 assay and flow cytometry. We found that UBR5 is abundantly overexpressed in CRC tissues than adjacent non-cancerous tissues. We also found that high UBR5 level is positively correlated with progression and poor survival in CRC patients. In addition, further multivariate analysis indicated that UBR5 and TNM stage were independent prognostic factors for overall survival in patients with CRC. Furthermore, we demonstrated that the expression of UBR5 was significantly elevated in CRC cell lines. Overexpression of UBR5 enhanced in vitro cell proliferation and promoted in vivo tumor growth, whereas silencing UBR5 suppressed growth of CRC cells. Moreover, our findings show that UBR5 promotes CRC cell proliferation by inducing cell cycle progression and suppressing cell apoptosis. Finally, we found that UBR5 directly binds to the tumor suppressor esophageal cancer-related gene 4 (ECRG4) and increased its ubiquitination to reduce the protein stability of ECRG4. We identified a tumorigenic role of UBR5 in CRC and provided a novel therapeutic target for CRC patients.
引用
收藏
页码:2781 / 2789
页数:9
相关论文
共 50 条
  • [31] Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis - A short Report
    You, Yanjie
    Li, Haijun
    Qin, Xin
    Ran, Yonggang
    Wang, Fei
    CELLULAR ONCOLOGY, 2016, 39 (01) : 89 - 95
  • [32] ECRG4 acts as a tumor suppressor in nasopharyngeal carcinoma by suppressing the AKT/GSK3β/β-catenin signaling pathway
    Zhengyuan Yang
    Xiajun Ye
    Yujie Zhang
    Yiteng Huang
    Jian Chen
    Yunzhu Zeng
    Jiongyu Chen
    Cytotechnology, 2022, 74 : 231 - 243
  • [33] ECRG4 acts as a tumor suppressor in nasopharyngeal carcinoma by suppressing the AKT/GSK3β/β-catenin signaling pathway
    Yang, Zhengyuan
    Ye, Xiajun
    Zhang, Yujie
    Huang, Yiteng
    Chen, Jian
    Zeng, Yunzhu
    Chen, Jiongyu
    CYTOTECHNOLOGY, 2022, 74 (02) : 231 - 243
  • [34] Cell surface localization and release of the candidate tumor suppressor Ecrg4 from polymorphonuclear cells and monocytes activate macrophages
    Baird, Andrew
    Coimbra, Raul
    Dang, Xitong
    Lopez, Nicole
    Lee, Jisook
    Krzyzaniak, Michael
    Winfield, Robert
    Potenza, Bruce
    Eliceiri, Brian P.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 91 (05) : 773 - 781
  • [35] Significance of the E3 ubiquitin protein UBR5 as an oncogene and a prognostic biomarker in colorectal cancer
    Xie, Zhongdong
    Liang, Han
    Wang, Jinmeng
    Xu, Xiaowen
    Zhu, Yan
    Guo, Aizhen
    Shen, Xian
    Cao, Fuao
    Chang, Wenjun
    ONCOTARGET, 2017, 8 (64) : 108079 - 108092
  • [36] Cell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4
    Dang, Xitong
    Podvin, Sonia
    Coimbra, Raul
    Eliceiri, Brian
    Baird, Andrew
    CELL AND TISSUE RESEARCH, 2012, 348 (03) : 505 - 514
  • [37] Cell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4
    Xitong Dang
    Sonia Podvin
    Raul Coimbra
    Brian Eliceiri
    Andrew Baird
    Cell and Tissue Research, 2012, 348 : 505 - 514
  • [38] Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages
    Mei Song
    Oladapo O. Yeku
    Sarwish Rafiq
    Terence Purdon
    Xue Dong
    Lijing Zhu
    Tuo Zhang
    Huan Wang
    Ziqi Yu
    Junhua Mai
    Haifa Shen
    Briana Nixon
    Ming Li
    Renier J. Brentjens
    Xiaojing Ma
    Nature Communications, 11
  • [39] The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma (Retraction of vol 29, artn no. 133, 2010)
    Li, Linwei
    Zhang, Chunpeng
    Li, Xiaoyan
    Lu, ShihHsin
    Zhou, Yun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
  • [40] Cell specific processing and release of the pro-hormone candidate tumor suppressor, Ecrg4, from the epithelial cell surface
    Dang, Xitong
    Podvin, Sonia
    Coimbra, Raul
    Eliceiri, Brian
    Baird, Andrew
    FASEB JOURNAL, 2012, 26